CVS Health (CVS)
(Delayed Data from NYSE)
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
Zacks News
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $104.16 in the latest trading session, marking a +0.97% move from the prior day.
CVS Health (CVS) Stock Moves -0.02%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $103.68 in the latest trading session, marking a -0.02% move from the prior day.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $101.31, marking a +0.41% move from the previous day.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $100.90 in the latest trading session, marking a +0.11% move from the prior day.
CVS Health (CVS) Scales a 52-Week High: What's Driving It?
by Zacks Equity Research
Robust performance by the Pharmacy Services and Health Care Benefits arms is driving the top line for CVS Health (CVS).
CVS Health (CVS) Outlines Growth Strategy, Initiates 2022 View
by Zacks Equity Research
CVS Health's (CVS) new strategy capitalizes on the considerable opportunity to make health care more convenient, personalized and affordable for consumers.
The Zacks Analyst Blog Highlights: UNH, PG, CVS, SQ, and ABB
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UNH, PG, CVS, SQ, and ABB.
Top Analyst Reports for UnitedHealth, Procter & Gamble & CVS
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), The Procter & Gamble Company (PG), and CVS Health Corporation (CVS).
CVS Health (CVS) New Alliance to Boost Digital Transformation
by Zacks Equity Research
CVS Health's (CVS) collaboration with Microsoft will accelerate digital transformation and empower employees to provide more customized and affordable care.
Microsoft (MSFT) to Support CVS Health's Digital Transformation
by Zacks Equity Research
Microsoft (MSFT) will be teaming up with CVS Health to advance work on developing innovative solutions to boost customer health outcomes.
Here's Why You Should Retain CVS Health (CVS) Stock for Now
by Zacks Equity Research
Investors are optimistic about CVS Health (CVS) on strong third-quarter 2021 results and raised full-year outlook.
CVS Health (CVS) Down 4.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top Stock Reports for Coca-Cola, Shopify & Advanced Micro Devices
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including The Coca-Cola Company (KO), Shopify Inc. (SHOP), and Advanced Micro Devices, Inc. (AMD).
CVS Health (CVS) Installs Time-Delay Safes in Texas Pharmacies
by Zacks Equity Research
CVS Health's (CVS) time-delay safes reduce theft and diversion of opioid medications and boost the security of stores, creating a safe environment for patients and staff.
CVS Health's (CVS) New Measures to Boost Omnichannel Health
by Zacks Equity Research
CVS Health's (CVS) new measures will support its strategy of making health care more affordable, accessible and convenient for consumers.
Best Growth Stocks to Buy for November 19th
by Zacks Equity Research
HHR, CVS, PSX, and HCCI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 19, 2021.
Zacks Industry Outlook Highlights: CVS Health, Rite Aid and Amazon
by Zacks Equity Research
Zacks Industry Outlook Highlights: CVS Health, Rite Aid and Amazon
Top Research Reports for Microsoft, Berkshire Hathaway & Oracle
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Berkshire Hathaway Inc. (BRK.B), and Oracle Corporation (ORCL).
2 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Headwinds
by Urmimala Biswas
The Zacks Retail Pharmacy and Drugstore industry is gaining from the growing demand for digital healthcare support. Industry players like CVS and RAD are likely to gain the most. However, reimbursement challenges are hurting the overall industry health.
CVS Health (CVS) Q3 Earnings Top Estimates, 2021 EPS View Up
by Zacks Equity Research
Strength in all three operating segments drove CVS Health's (CVS) revenues in the third quarter of 2021.
CVS Health (CVS) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 10.06% and 5.05%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Sprouts Farmers (SFM) to Post Q3 Earnings: Key Aspects to Note
by Zacks Equity Research
Sprouts Farmers (SFM) third-quarter performance is likely to have been affected by moderation of at-home dining trends.
Is a Surprise Coming for CVS Health (CVS) This Earnings Season?
by Zacks Equity Research
CVS Health (CVS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
CVS Health (CVS) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
CVS Health's (CVS) consumer-centric digital approach to administering vaccines across the nation is expected to have strongly contributed to its Q3 performance.
Zacks Earnings ESP: A Better Way to Find Earnings Surprises for Retail and Wholesale
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.